Describing perspectives of health care professionals on active surveillance for the management of prostate cancer-Reference-Cited by-同舟云学术

Describing perspectives of health care professionals on active surveillance for the management of prostate cancer

Published:2018-06-08 Issue:1 Volume:18 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Pang Kittie,Fitch Margaret,Ouellet Veronique,Chevalier Simone,Drachenberg Darrel E.,Finelli Antonio,Lattouf Jean-Baptiste,So Alan,Sutcliffe Simon,Tanguay Simon,Saad Fred^ORCID,Mes-Masson Anne-Marie

Funder

Terry Fox Research Institute

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-018-3273-9.pdf

Reference20 articles.

1. Thomsen FB, Roder MA, Hvarness H, Iversen P, Brasso K. Active surveillance can reduce overtreatment in patients with low-risk prostate cancer. Dan Med J. 2013;60(2):A4575.

2. Network NCC: NCCN clinical Practive guidelines in oncology - prostate Cancer. 2017.

3. Klotz L. Active surveillance for low-risk prostate cancer. F1000 Med Rep. 2012;4:16.

4. Dall’Era MA. Patient and disease factors affecting the choice and adherence to active surveillance. Curr Opin Urol. 2015;25(3):272–6.

5. Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012;87(3):369–74.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer;JAMA Network Open;2023-10-17

2. Adherence to discharge protocols and prostate‐specific antigen surveillance plans in men without a prostate cancer diagnosis;International Journal of Urological Nursing;2021-12-08

3. Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study;BMJ Open;2021-11

4. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists;BMC Cancer;2021-05-31

5. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review;European Urology Oncology;2021-04